正在為您準備內容...
正在為您準備內容...
成份 · Ingredient
馬拉韋羅
馬拉韋羅是一種CCR5受體拮抗劑類抗反轉錄病毒藥物。它通過阻斷HIV-1病毒表面的gp120蛋白與人體細胞表面的CCR5受體結合,防止CCR5親和性HIV-1病毒進入細胞,從而抑制病毒複製。此藥物專門用於治療對CCR5受體有親和性的HIV-1感染。
Maraviroc is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of 4,4-difluorocyclohexanecarboxylic acid and the primary amino group of (1S)-3-[(3-exo)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropylamine. An antiretroviral drug, it prevents the interaction of HIV-1 gp120 and chemokine receptor 5 (CCR5) necessary for CCR5-tropic HIV-1 to enter cells. It has a role as an antiviral drug, a HIV fusion inhibitor and a chemokine receptor 5 antagonist. It is a monocarboxylic acid amide, a member of triazoles, an organofluorine compound and an azabicycloalkane.
藥品資料來源:香港衞生署藥物辦公室 · 化學資料來源:PubChem (NIH) · 資料僅供參考,不構成醫療建議